Approvals/TGA/CSL USA HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection vials

Approved

STANDARD

CSL USA HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection vials

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ce4fc446751e2619
Product Name: CSL USA HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection vials
Artg Id: 385721
Artg Name: CSL USA HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection vials
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2022-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

ce4fc446751e2619

Type

Standard